Inhibition of corneal neovascularization with plasmid pigment epithelium-derived factor (p-PEDF) delivered by synthetic amphiphile INTeraction-18 (SAINT-18) vector in an experimental model of rat corneal angiogenesis

Experimental Eye Research

Volumn 89, Issue 5, 2009, Pages 678-685

  Kuo, Chien Neng ^a,b   Yang, Lin Cheng ^c   Yang, Cheng Ta ^a   Lai, Chien Hsiung ^a,b   Chen, Miao Fen ^a   Chen, Chung Yi ^d,e   Chen, Chi Hung ^e   Wu, Pei Chang ^a,b   Kou, Hsi Kung ^a,b   Chen, Yung Jen ^a,b   Hung, Chia Hui ^f   Tsai, Chong Bin ^f  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^c I SHOU UNIVERSITY   (Taiwan)

^d FOOYIN UNIVERSITY   (Taiwan)

^e NATIONAL CHIAYI UNIVERSITY   (Taiwan)

^f CHIA YI CHRISTIAN HOSPITAL   (Taiwan)

Author keywords

angiogenesis; cornea; fibroblast growth factor; nonviral vector; pigment epithelium derived factor; SAINT 18 (synthetic amphiphile interaction 18), 1 methyl 4 (cis 9 dioleyl)methylpyridinium chloride

Indexed keywords

1 METHYL 4 (9 DIOLEYL)METHYLPYRIDINIUM CHLORIDE; BASIC FIBROBLAST GROWTH FACTOR; DRUG CARRIER; HLA DR ANTIGEN; PIGMENT EPITHELIUM DERIVED FACTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC GENE THERAPY; ARTICLE; BIOMICROSCOPY; CONJUNCTIVA; CONTROLLED STUDY; CORNEA LIMBUS; CORNEA NEOVASCULARIZATION; CORNEA STROMA; DRUG EFFICACY; GENE EXPRESSION; GENE TRANSFER; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CONJUNCTIVA; CORNEA; CORNEAL NEOVASCULARIZATION; DISEASE MODELS, ANIMAL; EYE PROTEINS; FEASIBILITY STUDIES; FIBROBLAST GROWTH FACTOR 2; GENE THERAPY; HLA-DR ANTIGENS; IMMUNOHISTOCHEMISTRY; INJECTIONS; MALE; NERVE GROWTH FACTORS; PYRIDINIUM COMPOUNDS; RATS; RATS, SPRAGUE-DAWLEY; SERPINS; TIME FACTORS; TRANSFECTION;

EID: 70349459725     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exer.2009.06.021     Document Type: Article

References (38)

1. Adamis A.P., Meklir B., and Joyce N.C. In situ injury-induced release of basic-fibroblast growth factor from corneal epithelial cells. Am. J. Pathol. 139 (1991) 961-967
2. Akimoto M., Miyatake S., Kogishi J., Hangai M., Okazaki K., Takahashi J.C., Saiki M., Iwaki M., and Honda Y. Adenovirally expressed basic fibroblast growth factor rescues photoreceptor cells in RCS rats. Invest. Ophthalmol. Vis. Sci. 40 (1999) 273-279
3. Alavi A., Hood J.D., Frausto R., Stupack D.G., and Cheresh D.A. Role of Raf in vascular protection from distinct apoptotic stimuli. Science 301 (2003) 94-96
4. Ambati B.K., Joussen A.M., Ambati J., Moromizato Y., Guha C., Javaherian K., Gillies S., O'Reilly M.S., and Adamis A.P. Angiostatin inhibits and regresses corneal neovascularization. Arch. Ophthalmol. 120 (2002) 1063-1068
5. Amano S., Rohan R., Kuroki M., Tolentino M., and Adamis A.P. Requirement for vascular endothelial growth factor in wound- and inflammation-related corneal neovascularization. Invest. Ophthalmol. Vis. Sci. 39 (1998) 18-22
6. Aplin A.E., Howe A., Alahari S.K., and Juliano R.L. Signal transduction and signal modulation by cell adhesion receptors: the role of integrins, cadherins, immunoglobulin-cell adhesion molecules, and selectins. Pharmacol. Rev. 50 (1998) 197-263
7. Audouy S., Molema G., de Leij L., and Hoekstra D. Serum as a modulator of lipoplex-mediated gene transfection: dependence of amphiphile, cell type and complex stability. J. Gene Med. 2 (2000) 465-476
8. Becerra S.P. Focus on molecules: pigment epithelium-derived factor (PEDF). Exp. Eye Res. 82 (2006) 739-740
9. BenEzra D., Griffin B.W., Maftzir G., Sharif N.A., and Clark A.F. Topical formulations of novel angiostatic steroids inhibit rabbit corneal neovascularization. Invest. Ophthalmol. Vis. Sci. 38 (1997) 1954-1962
10. Boneham G.C., and Collin H.B. Steroid inhibition of limbal blood and lymphatic vascular cell growth. Curr. Eye Res. 14 (1995) 1-10
11. Benelli U., Bocci G., Danesi R., Lepri A., Bernardini N., Bianchi F., Lupetti M., Dolfi A., Campagni A., Agen C., Nardi M., and DelTacca M. The heparan sulfate suleparoide inhibits rat corneal angiogenesis and in vitro neovascularization. Exp. Eye Res. 67 (1998) 133-142
12. Bouck N. PEDF: anti-angiogenic guardian of ocular function. Trends. Mol. Med. 8 (2002) 330-334
13. Conway E.M., and Carmeliet P. Cardiovascular biology: signalling silenced. Nature 425 (2003) 139-141
14. Dawson D.W., Volpert O.V., Gillis P., Crawford S.E., Xu H., Benedict W., and Bouck N.P. Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Science 285 (1999) 245-248
15. Duh E.J., Yang H.S., Suzuma I., Miyagi M., Youngman E., Mori K., Katai M., Yan L., Suzuma K., West K., Davarya S., Tong P., Gehlbach P., Pearlman J., Crabb J.W., Aiello L.P., Campochiaro P.A., and Zack D.J. Pigment epithelium-derived factor suppresses ischemia-induced retinal neovascularization and VEGF-induced migration and growth. Invest. Ophthalmol. Vis. Sci. 43 (2002) 821-829
16. Fossarello M., Peiretti E., Zucca I., and Serra A. Photodynamic therapy of corneal neovascularization with verteporfin. Cornea 22 (2003) 485-488
17. Gordon Y.J., Mann R.K., Mah T.S., and Gorin M.B. Fluorescein-potentiated argon laser therapy improves symptoms and appearance of corneal neovascularization. Cornea 21 (2002) 770-773
18. Hill J.C., and Maske R. An animal model for corneal graft rejection in high-risk keratoplasty. Transplantation 46 (1988) 26-30
19. Jin J., Guan M., Sima J., Gao G., Zhang M., Liu Z., Fant J., and Ma J.X. Decreased pigment epithelium-derived factor and increased vascular endothelial growth factor levels in pterygia. Cornea 22 (2003) 473-477
20. Kanda S., Mochizuki Y., Nakamura T., Miyata Y., Matsuyama T., and Kanetake H. Pigment epithelium-derived factor inhibits fibroblast-growth-factor-2-induced capillary morphogenesis of endothelial cells through Fyn. J. Cell Sci. 118 (2005) 961-970
21. Kenyon B.M., Voest E.E., Chen C.C., Flynn E., Folkman J., and D'Amato R.J. A model of angiogenesis in the mouse cornea. Invest. Ophthalmol. Vis. Sci. 37 (1996) 1625-1632
22. Kenyon B.M., Browne F., and D'Amato R.J. Effects of thalidomide and related metabolites in a mouse corneal model of neovascularization. Exp. Eye Res. 64 (1997) 971-978
23. Klein-Soyer C., Beretz A., Cazenave J.P., Driot F., and Maffrand J.P. Behavior of confluent endothelial cells after irradiation. Modulation of wound repair by heparin and acidic fibroblast growth factor. Biol. Cell 68 (1990) 231-238
24. Kuo C.N., Yang L.C., Yang C.T., Chen M.F., Lai C.H., Chen Y.H., Chen C.H., Chen C.H., Wu P.C., Kou H.K., Tsai J.C., and Hung C.H. A novel vector system for gene transfer into the cornea using a partially dried plasmid expressing 18 basic fibroblast growth factor-synthetic amphiphile INTeraction-18 (SAINT-18) complex. Curr. Eye Res. 33 (2008) 839-848
25. Lai L.J., Xiao X., and Wu J.H. Inhibition of corneal neovascularization with endostatin delivered by adeno-associated viral (AAV) vector in a mouse corneal injury model. J. Biomed. Sci. 14 (2007) 313-322
26. Li W.W., Grayson G., Folkman J., and D'Amore P.A. Sustained-release endotoxin. A model for inducing corneal neovascularization. Invest. Ophthalmol. Vis. Sci. 32 (1991) 2906-2911
27. Ma D.H., Tsai R.J., Chu W.K., Kao C.H., and Chen J.K. Inhibition of vascular endothelial cell morphogenesis in cultures by limbal epithelial cells. Invest. Ophthalmol. Vis. Sci. 40 (1999) 1822-1828
28. Mohan R.R., Schultz G.S., Hong J.W., Mohan R.R., and Wilson S.E. Gene transfer into rabbit keratocytes using AAV and lipid-mediated plasmid DNA vectors with a lamellar flap for stromal access. Exp. Eye Res. 76 (2003) 373-383
29. Mahato R.I. Nonviral peptide-based approaches to gene delivery. J. Drug Target. 7 (1999) 249-268
30. Molina M.C., Allison S.D., and Anchordoquy T.J. Maintenance of nonviral vector particle size during the freezing step of the lyophilization process is insufficient for preservation of activity: insight from other structural indicators. J. Pharm. Sci. 90 (2001) 1445-1455
31. Ogata N., Wada M., Otsuji T., Jo N., Tombran-Tink J., and Matsumura M. Expression of pigment epithelium-derived factor in normal adult rat eye and experimental choroidal neovascularization. Invest. Ophthalmol. Vis. Sci. 43 (2002) 1168-1175
32. Ren J.G., Jie C., and Talbot C. How PEDF prevents angiogenesis: a hypothesized pathway. Med. Hypotheses 64 (2005) 74-78
33. Shewring L., Collins L., Lightman S.L., Hart S., Gustafsson K., and Fabre J.W. A nonviral vector system for efficient gene transfer to corneal endothelial cells via membrane integrins. Transplantation 64 (1997) 763-769
34. Suzuki T., Sano Y., and Kinoshita S. Effects of 1alpha,25-dihydroxyvitamin D3 on Langerhans cell migration and corneal neovascularization in mice. Invest. Ophthalmol. Vis. Sci. 41 (2000) 154-158
35. Tombran-Tink J., Chader G.G., and Johnson L.V. PEDF: a pigment epithelium-derived factor with potent neuronal differentiative activity. Exp. Eye Res. 53 (1991) 411-414
36. Tombran-Tink J., and Barnstable C.J. Therapeutic prospects for PEDF: more than a promising angiogenesis inhibitor. Trends. Mol. Med. 9 (2003) 244-250
37. Tsai R.J., Li L.M., and Chen J.K. Reconstruction of damaged corneas by transplantation of autologous limbal epithelial cells. N. Engl. J. Med. 343 (2000) 86-93
38. Van derWoude I., Wagenaar A., Meekel A.A., ter Beest M.B., Ruiters M.H., Engberts J.B., and Hoekstra D. Novel pyridinium surfactants for efficient, nontoxic in vitro gene delivery. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 1160-1165